13 /100
LOW RISK
Score updated May 29, 2026

ACAD — ACADIA Pharmaceuticals Inc. Dilution Risk Tracker

Track ACAD dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ACAD — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
0
📊 Float Risk
22
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for ACAD.
🔔 Track ACAD — Get forecast alerts →

💹 Market Data

Market Cap$3.70B
Shares Outstanding171.24M
Float127.34M
Cash$851.46M
Debt$50.79M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 3.5% shares (2025Q4 vs prior)
337 institutional holders · 168.58M shares
#1 BAKER BROS. ADVISORS LP 42.90M shares
#2 BlackRock, Inc. 20.76M shares
#3 VANGUARD GROUP INC 15.15M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest11.16M
Days to Cover5.9
% of Float8.8%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2012
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track ACAD Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ACAD — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for ACAD
📊 ACAD FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 ACAD Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.